CIBA CORNING ACS FT3 IMMUNOASSAY— 510(k) K940482

Name: FDA 510(k) clearance K940482
Creator: U.S. Food and Drug Administration
Published: 1994-04-26

Substantially Equivalent

Ciba Corning Diagnostics Corp.

FDA 510(k) clearance K940482 for CIBA CORNING ACS FT3 IMMUNOASSAY, Substantially Equivalent on 1994-04-26. Applicant: Ciba Corning Diagnostics Corp.. Device class: 2.

Clearance details

Applicant: Ciba Corning Diagnostics Corp.
Product code: Code CEC
Device class: Class 2
Regulation: 21 CFR 862.1695
Advisory panel: Clinical Chemistry
Date received: 1994-02-02
Decision date: 1994-04-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Medfield, MA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code CEC

view all

K240273 — Access Free T42024-03-06
K220456 — Elecsys FT4 IV2023-04-07
K182423 — MAGLUMI 2000 FT42018-10-04
K181233 — Elecsys FT4 III2018-09-18
K173122 — Abbott Architect Free T42017-10-27

More clearances from Ciba Corning Diagnostics Corp.

view all

K962559 — ACS CORTISOL IMMUNOASSAY1996-11-05
K963251 — CIBA CORNING ACS; 180 DPD ASSAY1996-10-15
K961807 — CERTAIN HCT LEVEL A & LEVEL B/CVM HCT LEVELS 1,2,3, & 41996-07-26
K961657 — CIBA CORNING 400 SYSTEM1996-06-25
K962021 — CIBA CORNING 348 SYSTEM1996-06-24

Adverse events under product code CEC

product code CEC

Malfunction: 899
Total: 899

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.